GATT Versus Canaloplasty (GVC)

Launched by MEDICAL UNIVERSITY OF BIALYSTOK · May 4, 2022

Keywords

ClinConnect Summary

This clinical trial, called GATT Versus Canaloplasty (GVC), is comparing two different surgical procedures for treating open-angle glaucoma, a common eye condition that can lead to vision loss. The two procedures being studied are Gonioscopy-assisted Transluminal Trabeculotomy (often called GATT) and canaloplasty. Both surgeries aim to lower eye pressure in patients whose glaucoma is not controlled with medication. The trial will look at which procedure is more effective, how safe each option is, and how many patients need to continue using medication after surgery.

To be eligible for the trial, participants must be at least 18 years old and have been diagnosed with uncontrolled open-angle glaucoma. They should not have had any previous glaucoma surgeries, although one prior laser treatment is allowed. The study is currently recruiting participants of any gender, and it’s important to note that certain types of glaucoma, like angle closure glaucoma or congenital glaucoma, will exclude individuals from participating. If you join the study, you can expect to receive one of the two surgeries and be monitored for your eye pressure, the need for medications, and any possible complications. This research is important because it will help determine the best surgical option for patients with this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 Years and older (Adult, Older Adult)
• • patients with confirmed uncontrolled open angle glaucoma
• • no prior glaucoma surgery (once laser trabeculoplasty or cyclophotocoagulation) allowed
• Exclusion Criteria:
• • angle closure glaucoma
• • congenital glaucoma
• • inflammatory glaucoma